Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionATP hydrolysis activity

KIF18A MYH3 ABCA1 ERCC3 VPS4B ABCC11 BTAF1 OLA1 DDX11 ATP2C2 DHX29 FIGNL1 DDX11L8

6.57e-0544116213GO:0016887
GeneOntologyMolecularFunctiontransketolase activity

TKTL1 TKT

1.95e-0431622GO:0004802
GeneOntologyMolecularFunctiontriplex DNA binding

DDX11 DDX11L8

3.88e-0441622GO:0045142
GeneOntologyMolecularFunctionDNA replication origin binding

ORC3 DDX11 DDX11L8

3.91e-04181623GO:0003688
GeneOntologyMolecularFunctionhistone H3 methyltransferase activity

NSD1 MECOM SETD2 SETBP1

4.40e-04441624GO:0140938
GeneOntologyMolecularFunctioncadherin binding

FLNA CD46 OLA1 CBL YWHAE PTPRB BAIAP2L1 EGFR DHX29 HDLBP

4.62e-0433916210GO:0045296
GeneOntologyMolecularFunctionATP-dependent activity

KIF18A MYH3 ABCA1 ERCC3 VPS4B ABCC11 BTAF1 OLA1 DDX11 ATP2C2 ATP6V1C2 DHX29 FIGNL1 DDX11L8

4.94e-0461416214GO:0140657
GeneOntologyMolecularFunctionS-adenosylmethionine-dependent methyltransferase activity

NSD1 TRMT11 MECOM SETD2 SETBP1 TRMT61B NOP2

5.18e-041721627GO:0008757
GeneOntologyMolecularFunctionactin binding

KIF18A FLNA MYH3 FLNC SPATA31A3 SPATA31A7 HIP1R SPATA31A5 SPATA31A1 BAIAP2L1 EGFR TNNT3

5.53e-0447916212GO:0003779
GeneOntologyMolecularFunctionthiolester hydrolase activity

OLAH ACOT9 ACOT4 HAGH

5.67e-04471624GO:0016790
GeneOntologyMolecularFunctiontransketolase or transaldolase activity

TKTL1 TKT

6.44e-0451622GO:0016744
GeneOntologyBiologicalProcessmale gamete generation

TDRD5 KIF18A SPATA31A3 ARMC3 STRBP SPATA31A7 APOB SPATA31A5 SPATA31D1 LIMK2 SPATA31A1 BRD2 BRCA2 SEC23IP POC1B CDY2A FAM9A FIGNL1 TARBP2

7.47e-0676216019GO:0048232
HumanPhenoOverlapping fingers

FLNA MYH3 MECOM MADD SETBP1 TNNT3

3.93e-0735446HP:0010557
HumanPhenoHypertelorism

FLNA MYH3 PSAT1 ERCC3 EMC1 NSD1 TOGARAM1 RREB1 CBL YWHAE POLR3A HIRA GREB1L NBAS BMP4 SETD2 UBE2T BRCA2 SETBP1

2.10e-058304419HP:0000316
HumanPhenoElevated circulating apolipoprotein A-II concentration

ABCA1 LPL

7.29e-052442HP:0031800
HumanPhenoIncreased circulating apolipoprotein circulation

ABCA1 LPL

7.29e-052442HP:0033460
HumanPhenoLong foot

FLNA NSD1 POLR3A SETD2

8.53e-0528444HP:0001833
HumanPhenoShort neck

FLNA MYH3 PSAT1 RREB1 CBL YWHAE MADD POLR3A HIRA NBAS SETBP1 TNNT3

9.24e-053984412HP:0000470
HumanPhenoAbnormality of the liver

FLNC ABCA1 NSD1 GBE1 MECOM TOGARAM1 APOB CD46 RREB1 GDF2 CBL NPHP4 HNRNPA2B1 MADD POLR3A HIRA NBAS UBE2T BRCA2 TKT LPL SETBP1

1.22e-0412054422HP:0001392
HumanPhenoNarrow mouth

FLNA MYH3 RREB1 YWHAE MADD POLR3A HIRA SETBP1 TNNT3

1.35e-04234449HP:0000160
HumanPhenoSyndactyly

FLNA MYH3 PSAT1 NSD1 MECOM POLR3A DDX11 NBAS BMP4 UBE2T BRCA2 SETBP1

1.45e-044174412HP:0001159
HumanPhenoPointed chin

FLNA MYH3 NSD1 MADD POLR3A SETD2 SETBP1

1.52e-04138447HP:0000307
HumanPhenoMalar flattening

FLNA MYH3 RREB1 POLR3A HIRA NBAS BMP4 SETD2 SETBP1

1.64e-04240449HP:0000272
HumanPhenoCraniosynostosis

FLNA MYH3 PSAT1 ERCC3 NSD1 RREB1 HIRA BMP4

1.81e-04190448HP:0001363
HumanPhenoAbnormal malar bone morphology

FLNA MYH3 RREB1 POLR3A HIRA NBAS BMP4 SETD2 SETBP1

2.17e-04249449HP:0012369
HumanPhenoLong phalanx of finger

FLNA NSD1

2.18e-043442HP:0006155
HumanPhenoAbnormal zygomatic arch morphology

FLNA MYH3 RREB1 POLR3A HIRA NBAS BMP4 SETD2 SETBP1

2.24e-04250449HP:0005557
HumanPhenoAbnormal zygomatic bone morphology

FLNA MYH3 RREB1 POLR3A HIRA NBAS BMP4 SETD2 SETBP1

2.24e-04250449HP:0010668
HumanPhenoAbnormality of the cervical spine

FLNA MYH3 PSAT1 RREB1 CBL YWHAE MADD POLR3A HIRA NBAS SETBP1 TNNT3

2.36e-044394412HP:0003319
HumanPhenoPolyhydramnios

MYH3 PSAT1 GBE1 RREB1 CBL YWHAE MADD HIRA GREB1L EGFR

2.46e-043124410HP:0001561
HumanPhenoAbnormal enteric ganglion morphology

NSD1 TOGARAM1 RREB1 HIRA UBE2T BRCA2 SETBP1

2.56e-04150447HP:0004362
HumanPhenoAganglionic megacolon

NSD1 TOGARAM1 RREB1 HIRA UBE2T BRCA2 SETBP1

2.56e-04150447HP:0002251
HumanPhenoMegacolon

NSD1 TOGARAM1 RREB1 HIRA UBE2T BRCA2 SETBP1

2.56e-04150447HP:6000852
HumanPhenoAbnormal autonomic nervous system morphology

NSD1 TOGARAM1 RREB1 HIRA UBE2T BRCA2 SETBP1

2.67e-04151447HP:0012331
HumanPhenoAbnormal enteric nervous system morphology

NSD1 TOGARAM1 RREB1 HIRA UBE2T BRCA2 SETBP1

2.67e-04151447HP:0025028
HumanPhenoAbnormality of cranial sutures

FLNA MYH3 PSAT1 ERCC3 NSD1 TOGARAM1 RREB1 POLR3A HIRA BMP4 SETBP1

3.34e-043884411HP:0011329
HumanPhenoMicrognathia

FLNA MYH3 PSAT1 ERCC3 EMC1 NSD1 RREB1 CBL MADD POLR3A HIRA BMP4 SETD2 UBE2T BRCA2 SETBP1 TNNT3

3.58e-048434417HP:0000347
HumanPhenoAplasia/Hypoplasia of the mandible

FLNA MYH3 PSAT1 ERCC3 EMC1 NSD1 RREB1 CBL MADD POLR3A HIRA BMP4 SETD2 UBE2T BRCA2 SETBP1 TNNT3

3.68e-048454417HP:0009118
HumanPhenoEpicanthus

FLNA MYH3 ERCC3 RREB1 CBL YWHAE MADD HIRA DDX11 GREB1L NBAS BMP4 UBE2T BRCA2

4.24e-046144414HP:0000286
HumanPhenoSacrococcygeal teratoma

NSD1 SETBP1

4.33e-044442HP:0030736
HumanPhenoAbnormal morphology of the radius

FLNA MYH3 MECOM CBL UBE2T BRCA2 SETBP1 TNNT3

4.48e-04217448HP:0002818
HumanPhenoAstigmatism

FLNA ERCC3 EMC1 NSD1 BMP4 UBE2T BRCA2 SETBP1

4.48e-04217448HP:0000483
HumanPhenoAbnormal eyelid morphology

FLNA MYH3 PSAT1 ABCA1 ERCC3 NSD1 APOB RREB1 CBL YWHAE MADD POLR3A HIRA DDX11 GREB1L NBAS BMP4 SETD2 UBE2T BRCA2 EGFR LPL SETBP1

4.49e-0414084423HP:0000492
HumanPhenoFinger syndactyly

MYH3 PSAT1 NSD1 MECOM BMP4 UBE2T BRCA2 SETBP1

4.62e-04218448HP:0006101
HumanPhenoAbnormal systemic arterial morphology

FLNA MYH3 ABCA1 ERCC3 NSD1 APOB RREB1 GDF2 CBL HIRA UBE2T BRCA2 EGFR TKT LPL

5.48e-047084415HP:0011004
HumanPhenoAbnormal anus morphology

IL10RA EMC1 RREB1 HIRA UBE2T BRCA2 EGFR SETBP1

5.54e-04224448HP:0034915
HumanPhenoAnterior bulging of the globe

FLNA PSAT1 CBL POLR3A NBAS BMP4 UBE2T BRCA2 SETBP1

5.62e-04283449HP:0000644
HumanPhenoLarge face

FLNA MYH3 NSD1 TOGARAM1 RREB1 HIRA NBAS SETD2 SETBP1

5.62e-04283449HP:0100729
HumanPhenoProptosis

FLNA PSAT1 CBL POLR3A NBAS BMP4 UBE2T BRCA2 SETBP1

5.62e-04283449HP:0000520
HumanPhenoSpina bifida

FLNA MYH3 PSAT1 RREB1 HIRA UBE2T BRCA2

5.70e-04171447HP:0002414
HumanPhenoAdvanced eruption of teeth

FLNA NSD1 POLR3A BMP4

6.07e-0446444HP:0006288
DomainLRRC37AB_C

LRRC37A3 LRRC37A2 LRRC37A

2.59e-0641633IPR029423
DomainLRRC37AB_C

LRRC37A3 LRRC37A2 LRRC37A

2.59e-0641633PF14914
DomainLRRC37_N

LRRC37A3 LRRC37A2 LRRC37A

2.59e-0641633IPR032754
DomainLRRC37

LRRC37A3 LRRC37A2 LRRC37A

2.59e-0641633PF15779
DomainLRRC37A/B-like

LRRC37A3 LRRC37A2 LRRC37A

2.59e-0641633IPR015753
DomainDUF4599

SPATA31A3 SPATA31A7 SPATA31A5 SPATA31D1

2.62e-06121634PF15371
DomainDUF4599

SPATA31A3 SPATA31A7 SPATA31A5 SPATA31D1

2.62e-06121634IPR027970
DomainIG_FLMN

FLNA FLNC POGLUT2

7.49e-05101633SM00557
DomainTransketolase_BS

TKTL1 TKT

7.57e-0521632IPR020826
DomainFilamin

FLNA FLNC POGLUT2

1.02e-04111633PF00630
DomainFILAMIN_REPEAT

FLNA FLNC POGLUT2

1.02e-04111633PS50194
DomainFilamin/ABP280_rpt

FLNA FLNC POGLUT2

1.02e-04111633IPR001298
DomainFilamin/ABP280_repeat-like

FLNA FLNC POGLUT2

1.02e-04111633IPR017868
DomainTransketolase_N

TKTL1 TKT

2.26e-0431632PF00456
DomainTransketolase_N

TKTL1 TKT

2.26e-0431632IPR005474
DomainTRANSKETOLASE_1

TKTL1 TKT

2.26e-0431632PS00801
DomainTRANSKETOLASE_2

TKTL1 TKT

2.26e-0431632PS00802
DomainAWS

NSD1 SETD2

7.44e-0451632SM00570
DomainTransketolase_C

TKTL1 TKT

7.44e-0451632IPR033248
DomainTransketolase_fam

TKTL1 TKT

7.44e-0451632IPR033247
DomainAWS

NSD1 SETD2

7.44e-0451632PS51215
DomainAWS_dom

NSD1 SETD2

7.44e-0451632IPR006560
DomainTransketo_C/PFOR_II

TKTL1 TKT

7.44e-0451632IPR009014
DomainTransketolase_C

TKTL1 TKT

7.44e-0451632PF02780
Domain-

TKTL1 TKT

7.44e-04516323.40.50.920
Pubmed

The testis-specific VAD1.3/AEP1 interacts with β-actin and syntaxin 1 and directs peri-nuclear/Golgi expression with bipartite nucleus localization (BNL) sequence.

SPATA31A3 SPATA31A7 SPATA31A5 SPATA31A1

7.45e-096166420850414
Pubmed

Targeted disruption of the spermatid-specific gene Spata31 causes male infertility.

SPATA31A3 SPATA31A7 SPATA31A5 SPATA31A1

7.45e-096166425930072
Pubmed

A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.

ZC3H14 FLNA FLNC ERCC3 COPA ACOT9 STRBP CNOT10 HMMR OLA1 HIRA TKT GKAP1 DCLRE1A SPATS2 NOP2 DHX29 HDLBP

1.37e-087241661836232890
Pubmed

Primate segmental duplication creates novel promoters for the LRRC37 gene family within the 17q21.31 inversion polymorphism region.

LRRC37A3 LRRC37A2 LRRC37A

4.26e-074166322419166
Pubmed

Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.

TPTE STRBP NSD1 YWHAE POLR3A GCNT7 BRD2 UBE2T EGFR LIPM MAP4K1 ATP2C2 POC1B GALNT5 MMP12 TUBE1

4.92e-077301661634857952
Pubmed

Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.

EMC1 ORC3 ACOT9 STRBP DIDO1 BTAF1 HMMR MADD POLR3A SLC30A5 TRAM1 LPL CLSPN FIGNL1 DDX11L8

6.00e-076501661538777146
Pubmed

The cell proliferation antigen Ki-67 organises heterochromatin.

IPO5 ZC3H14 KIF18A MYH3 ERCC3 CNOT10 DIDO1 PARP14 HIRA KNOP1 BAIAP2L1 SPATS2

7.31e-074101661226949251
Pubmed

HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.

ZC3H14 FLNA COPA STRBP HNRNPA3 DIDO1 APOB HNRNPA2B1 SETD2 BRCA2 ODR4 GALNT5 NOP2 IMMT MAP3K19 HDLBP

7.52e-077541661635906200
Pubmed

The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.

ZC3H14 ERCC3 EMC1 ORC3 CNOT10 HIP1R NSD1 DIDO1 HMMR OLA1 YWHAE HIRA KNOP1 GREB1L SETD2 BRD2 UBP1 TRAM1 SPATS2 DHX29 IMMT TARBP2 HDLBP

7.93e-0714971662331527615
Pubmed

The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.

ZC3H14 FLNA CWF19L2 BAZ2B STRBP HNRNPA3 NSD1 DIDO1 RREB1 YWHAE HNRNPA2B1 KNOP1 SETD2 BRD2 BRCA2 NOP2 IMMT HDLBP

8.06e-079541661836373674
Pubmed

Nephrocystin-conserved domains involved in targeting to epithelial cell-cell junctions, interaction with filamins, and establishing cell polarity.

FLNA FLNC NPHP4

1.06e-065166312006559
Pubmed

Association of genome-wide variation with highly sensitive cardiac troponin-T levels in European Americans and Blacks: a meta-analysis from atherosclerosis risk in communities and cardiovascular health studies.

DLGAP1 RREB1 TRAM1 ATP6V1C2

3.42e-0622166423247143
Pubmed

Structural flexibility regulates phosphopeptide-binding activity of the tyrosine kinase binding domain of Cbl-c.

CBL EGFR FGFR4

3.69e-067166322888118
Pubmed

Majority of cerebrospinal fluid-contacting neurons in the spinal cord of C57Bl/6N mice is present in ectopic position unlike in other studied experimental mice strains and mammalian species.

SPATA31A3 SPATA31A7 SPATA31A5 SPATA31A1

4.94e-0624166432212159
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

FLNA COPA DIDO1 BTAF1 RREB1 HNRNPA2B1 SETD2 BRD2 EGFR TKT MAP4K1 ZBTB40 NOP2 DHX29 HDLBP

5.08e-067741661515302935
Pubmed

Genetic polymorphisms affecting the phenotypic expression of familial hypercholesterolemia.

ABCA1 APOB LPL

5.88e-068166315135251
Pubmed

PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.

ZC3H14 FLNA BAZ2B ORC3 HNRNPA3 GBE1 DIDO1 HMMR OLA1 GMEB2 RREB1 HNRNPA2B1 TNRC18 RESF1 TKT ZBTB40 NOP2 HDLBP

6.10e-0611031661834189442
Pubmed

Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.

IPO5 FLNA FLNC EMC1 COPA ACOT9 HNRNPA3 GBE1 CBL YWHAE HNRNPA2B1 SLC30A5 EGFR ODR4 TKT TRAM1 NEIL3 HAGH POGLUT2 IMMT HDLBP

6.28e-0614511662130550785
Pubmed

Large-scale proteomics and phosphoproteomics of urinary exosomes.

FLNA MYH3 PSAT1 ARMC3 VPS4B APAF1 GBE1 ABCC11 SCEL OLA1 RREB1 GDF2 YWHAE BAIAP2L1 TKT ATP6V1C2 FIGNL1

8.12e-0610161661719056867
Pubmed

Polymorphisms associated with cholesterol and risk of cardiovascular events.

ABCA1 APOB LPL

8.78e-069166318354102
Pubmed

A gene score of nine LDL and HDL regulating genes is associated with fluvastatin-induced cholesterol changes in women.

ABCA1 APOB LPL

8.78e-069166319773416
Pubmed

BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.

IPO5 FLNA COPA ACOT9 HNRNPA3 HIP1R OLA1 PARP14 HNRNPA2B1 ITIH2 TKT NOP2 IMMT HDLBP

8.89e-067111661433022573
Pubmed

Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.

ZC3H14 FLNA ERCC3 COPA ACOT9 HNRNPA3 DIDO1 HMMR YWHAE HNRNPA2B1 ITIH2 KNOP1 BAIAP2L1 EGFR TKT SPATS2 NOP2 IMMT HDLBP

9.82e-0612571661936526897
Pubmed

Identification of proximal SUMO-dependent interactors using SUMO-ID.

KIF18A FLNA FLNC CWF19L2 ERCC3 HMMR GMEB2 HIRA RESF1 BRCA2 HDLBP

1.04e-054441661134795231
Pubmed

Hypertonicity-responsive ubiquitin ligase RNF183 promotes Na, K-ATPase lysosomal degradation through ubiquitination of its β1 subunit.

IPO5 FLNA EMC1 COPA CNOT10 ARFIP1 YWHAE SLC30A5 SNX6 SEC23IP HDLBP

1.15e-054491661131732153
Pubmed

Evolutionary dynamism of the primate LRRC37 gene family.

LRRC37A3 LRRC37A2 LRRC37A

1.25e-0510166323064749
Pubmed

Proteomic and Interactome Approaches Reveal PAK4, PHB-2, and 14-3-3η as Targets of Overactivated Cdc42 in Cellular Responses to Genomic Instability.

IPO5 FLNC PSAT1 COPA OLA1 NOP2 MAP3K19 HDLBP

1.36e-05225166831478661
Pubmed

The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.

ZC3H14 KIF18A ERCC3 COPA STRBP HNRNPA3 DIDO1 HMMR HNRNPA2B1 KNOP1 SPATS2 NOP2 DHX29 TARBP2

1.84e-057591661435915203
Pubmed

Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.

COPA STRBP YWHAE MADD RPS6KC1 UBP1 SPATS2 NOP2 DHX29 IMMT HDLBP

1.94e-054751661131040226
Pubmed

Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts.

ABCA1 APOB MADD LPL

2.08e-0534166419060911
Pubmed

EWSR1-induced circNEIL3 promotes glioma progression and exosome-mediated macrophage immunosuppressive polarization via stabilizing IGF2BP3.

STRBP HNRNPA3 YWHAE HNRNPA2B1 LPL NEIL3 HDLBP

2.16e-05174166735031058
Pubmed

Knockout of c-Cbl slows EGFR endocytic trafficking and enhances EGFR signaling despite incompletely blocking receptor ubiquitylation.

CBL EGFR

2.26e-052166233811466
Pubmed

Role of candidate genes in the lipid responses to intensified treatment in Type 2 diabetes.

APOB LPL

2.26e-052166216419488
Pubmed

HPV16 E5 protein disrupts the c-Cbl-EGFR interaction and EGFR ubiquitination in human foreskin keratinocytes.

CBL EGFR

2.26e-052166215735736
Pubmed

Hepatic ABCA1 deficiency is associated with delayed apolipoprotein B secretory trafficking and augmented VLDL triglyceride secretion.

ABCA1 APOB

2.26e-052166228694219
Pubmed

Ecotropic viral integration site 1 regulates EGFR transcription in glioblastoma cells.

MECOM EGFR

2.26e-052166231617054
Pubmed

Filamin isogene expression during mouse myogenesis.

FLNA FLNC

2.26e-052166210679933
Pubmed

A novel structural unit in the N-terminal region of filamins.

FLNA FLNC

2.26e-052166224469451
Pubmed

Cbl-mediated ubiquitinylation is required for lysosomal sorting of epidermal growth factor receptor but is dispensable for endocytosis.

CBL EGFR

2.26e-052166212754251
Pubmed

Peritumoral Cbl is a strong independent prognostic marker after curative resection of hepatocellular carcinoma.

CBL EGFR

2.26e-052166226474280
Pubmed

RASopathy-associated CBL germline mutations cause aberrant ubiquitylation and trafficking of EGFR.

CBL EGFR

2.26e-052166225178484
Pubmed

Insulin receptor tyrosine kinase substrate activates EGFR/ERK signalling pathway and promotes cell proliferation of hepatocellular carcinoma.

BAIAP2L1 EGFR

2.26e-052166223693078
Pubmed

Enhanced apoB48 metabolism in lipoprotein lipase X447 homozygotes.

APOB LPL

2.26e-052166216989840
Pubmed

Dynamic histone H3 methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation.

NSD1 SETD2

2.26e-052166218157086
Pubmed

Interactions of Drosophila Cbl with epidermal growth factor receptors and role of Cbl in R7 photoreceptor cell development.

CBL EGFR

2.26e-05216629121472
Pubmed

Role of thiamine status and genetic variability in transketolase and other pentose phosphate cycle enzymes in the progression of diabetic nephropathy.

TKTL1 TKT

2.26e-052166220826743
Pubmed

NSD1 Inactivation and SETD2 Mutation Drive a Convergence toward Loss of Function of H3K36 Writers in Clear Cell Renal Cell Carcinomas.

NSD1 SETD2

2.26e-052166228754676
Pubmed

Termination of tyrphostin AG1478 application results in different recovery of EGF receptor tyrosine residues 1045 and 1173 phosphorylation in A431 cells.

CBL EGFR

2.26e-052166219947936
Pubmed

Induction of Cbl-dependent epidermal growth factor receptor degradation in Ling Zhi-8 suppressed lung cancer.

CBL EGFR

2.26e-052166228198003
Pubmed

BMP signaling induces visceral endoderm differentiation of XEN cells and parietal endoderm.

LAMA1 BMP4

2.26e-052166222027433
Pubmed

Expression and prognostic value of NSD1 and SETD2 in pancreatic ductal adenocarcinoma and its precursor lesions.

NSD1 SETD2

2.26e-052166231060750
Pubmed

Apolipoprotein B production reduces lipotoxic cardiomyopathy: studies in heart-specific lipoprotein lipase transgenic mouse.

APOB LPL

2.26e-052166214634011
Pubmed

Low expression of the E3 ubiquitin ligase CBL confers chemoresistance in human pancreatic cancer and is targeted by epidermal growth factor receptor inhibition.

CBL EGFR

2.26e-052166225348515
Pubmed

The RING finger of c-Cbl mediates desensitization of the epidermal growth factor receptor.

CBL EGFR

2.26e-052166210428778
Pubmed

FLNa negatively regulated proliferation and metastasis in lung adenocarcinoma A549 cells via suppression of EGFR.

FLNA EGFR

2.26e-052166229272322
Pubmed

Molecular mechanisms of cigarette smoke-induced proliferation of lung cells and prevention by vitamin C.

CBL EGFR

2.26e-052166221772844
Pubmed

Mapping of two genes encoding isoforms of the actin binding protein ABP-280, a dystrophin like protein, to Xq28 and to chromosome 7.

FLNA FLNC

2.26e-05216627689010
Pubmed

Impaired degradation followed by enhanced recycling of epidermal growth factor receptor caused by hypo-phosphorylation of tyrosine 1045 in RBE cells.

CBL EGFR

2.26e-052166222591401
Pubmed

A novel dileucine lysosomal-sorting-signal mediates intracellular EGF-receptor retention independently of protein ubiquitylation.

CBL EGFR

2.26e-052166216105874
Pubmed

Hypophosphorylation of residue Y1045 leads to defective downregulation of EGFRvIII.

CBL EGFR

2.26e-052166216969069
Pubmed

Filamin A modulates kinase activation and intracellular trafficking of epidermal growth factor receptors in human melanoma cells.

FLNA EGFR

2.26e-052166219213840
Pubmed

[Relationship of gallstone formation after radical gastrectomy with the polymorphisms of apolipoprotein B Xba I and lipoprotein lipase Hind III gene].

APOB LPL

2.26e-052166220099167
Pubmed

Identification of Predictive ERBB Mutations by Leveraging Publicly Available Cell Line Databases.

CBL EGFR

2.26e-052166233323455
Pubmed

Directional ABCA1-mediated cholesterol efflux and apoB-lipoprotein secretion in the retinal pigment epithelium.

ABCA1 APOB

2.26e-052166230076206
Pubmed

Identification of an AAA ATPase VPS4B-dependent pathway that modulates epidermal growth factor receptor abundance and signaling during hypoxia.

VPS4B EGFR

2.26e-052166222252323
Pubmed

A δ38 deletion variant of human transketolase as a model of transketolase-like protein 1 exhibits no enzymatic activity.

TKTL1 TKT

2.26e-052166223118983
Pubmed

Pyruvate dehydrogenase kinase 4 promotes osteoblastic potential of BMP9 by boosting Wnt/β-catenin signaling in mesenchymal stem cells.

PDK4 GDF2

2.26e-052166236442735
Pubmed

(-)-Epigallocatechin gallate downregulates EGF receptor via phosphorylation at Ser1046/1047 by p38 MAPK in colon cancer cells.

CBL EGFR

2.26e-052166219578043
Pubmed

Is transketolase-like protein, TKTL1, transketolase?

TKTL1 TKT

2.26e-052166223261987
Pubmed

Peptide truncation leads to a twist and an unusual increase in affinity for casitas B-lineage lymphoma tyrosine kinase binding domain.

CBL EGFR

2.26e-052166222394513
Pubmed

A possible mechanism behind autoimmune disorders discovered by genome-wide linkage and association analysis in celiac disease.

TPTE UBE2T SNX6 TNNT3

2.33e-0535166423936387
Pubmed

Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.

IPO5 COPA ORC3 HNRNPA3 HIP1R BTAF1 OLA1 ARFIP1 YWHAE HNRNPA2B1 BRD2 HDLBP

2.54e-055821661220467437
Pubmed

CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.

IPO5 FLNA FLNC COPA HNRNPA3 HMMR YWHAE HNRNPA2B1 TKT SEC23IP NOP2

2.78e-054941661126831064
Pubmed

Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.

IPO5 ZC3H14 FLNA PSAT1 ERCC3 COPA ACOT9 VPS4B HNRNPA3 HMMR OLA1 YWHAE HNRNPA2B1 BMP4 TNRC18 SPATS2 IMMT HDLBP

3.13e-0512471661827684187
Pubmed

HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.

FLNA ERCC3 COPA STRBP DAB1 DIDO1 APOB HMMR OLA1 YWHAE HNRNPA2B1 ITIH2 KNOP1 TKT HAGH SPATS2 NOP2 TARBP2 HDLBP

3.24e-0513711661936244648
Pubmed

Maternal genes and facial clefts in offspring: a comprehensive search for genetic associations in two population-based cleft studies from Scandinavia.

ABCA1 MECOM APOB BMP4 EGFR EGR3 LPL FGFR4 TNNT3

3.29e-05331166920634891
Pubmed

Identifying biological pathways that underlie primordial short stature using network analysis.

IPO5 ZC3H14 FLNA FLNC EMC1 COPA STRBP HNRNPA3 BTAF1 OLA1 YWHAE HNRNPA2B1 BRD2 NOP2 IMMT HDLBP

3.47e-0510241661624711643
Pubmed

The in vivo Interaction Landscape of Histones H3.1 and H3.3.

IPO5 BAZ2B NSD1 DIDO1 BTAF1 RREB1 HIRA KNOP1 BRD2 ZBTB40 ZBTB10 NOP2

3.88e-056081661236089195
Pubmed

Faciogenital Dysplasia 5 supports cancer stem cell traits in basal-like breast cancer by enhancing EGFR stability.

FLNA FLNC PSAT1 CBL YWHAE EGFR TKT

3.92e-05191166733762435
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

ZC3H14 FLNA PSAT1 DIDO1 BTAF1 NUDCD3 ARFIP1 RTN1 KNOP1 SETD2 TKT SEC23IP NOP2 DHX29 HDLBP

4.52e-059341661533916271
Pubmed

Nuclear EGFR renders cells radio-resistant by binding mRNA species and triggering a metabolic switch to increase lactate production.

HNRNPA3 HNRNPA2B1 EGFR

4.66e-0515166326320552
Pubmed

Investigation of variants identified in caucasian genome-wide association studies for plasma high-density lipoprotein cholesterol and triglycerides levels in Mexican dyslipidemic study samples.

ABCA1 APOB LPL

4.66e-0515166320160193
Pubmed

H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.

ZC3H14 COPA BAZ2B ORC3 HNRNPA3 NSD1 MECOM DIDO1 RREB1 HNRNPA2B1 HIRA KNOP1 SETD2 BRD2 UBP1 TRAM1 DCLRE1A NOP2

5.04e-0512941661830804502
Pubmed

Network organization of the human autophagy system.

IPO5 FLNA FLNC COPA NUDCD3 YWHAE BAIAP2L1 TKT TRMT61B IMMT

5.16e-054371661020562859
Pubmed

Population based allele frequencies of disease associated polymorphisms in the Personalized Medicine Research Project.

APOB EGFR LPL FGFR4

5.34e-0543166420565774
Pubmed

LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.

IPO5 FLNA COPA BTAF1 PARP14 NBAS EGFR

5.59e-05202166733005030
Pubmed

Maternal and fetal variation in genes of cholesterol metabolism is associated with preterm delivery.

ABCA1 APOB LPL

5.71e-0516166317855807
Pubmed

Joint effects of common genetic variants from multiple genes and pathways on the risk of premature coronary artery disease.

ABCA1 APOB LPL

5.71e-0516166320691829
Pubmed

Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions.

CBL SLC30A5 BRD2 BRCA2 EGFR MAP4K1 SEC23IP FGFR4

5.81e-05276166828319085
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

FLNA MYH3 FLNC PCDHGC5 ARMC3 COPA STRBP HNRNPA3 APOB TKTL1 HNRNPA2B1 KNOP1 RPS6KC1 DDX11 TNRC18 BRD2 TKT SEC23IP IMMT

6.36e-0514421661935575683
Pubmed

Physiological and pathophysiological characteristics of ataxin-3 isoforms.

FLNA PSAT1 COPA ACOT9 YWHAE HNRNPA2B1 TKT HAGH

6.59e-05281166830455355
Pubmed

Src promotes destruction of c-Cbl: implications for oncogenic synergy between Src and growth factor receptors.

CBL EGFR

6.77e-053166212604776
Pubmed

[Single nucleotide polymorphisms of genes associated with high density lipoprotein metabolism in Chinese population].

ABCA1 LPL

6.77e-053166215696473
Pubmed

Intersectin regulates epidermal growth factor receptor endocytosis, ubiquitylation, and signaling.

CBL EGFR

6.77e-053166216914641
Pubmed

A novel role of Sprouty 2 in regulating cellular apoptosis.

CBL EGFR

6.77e-053166218070883
Pubmed

Cortactin promotes colorectal cancer cell proliferation by activating the EGFR-MAPK pathway.

CBL EGFR

6.77e-053166227903975
Pubmed

Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signaling.

CBL EGFR

6.77e-053166217486068
Pubmed

Recurrent gain-of-function USP8 mutations in Cushing's disease.

YWHAE EGFR

6.77e-053166225675982
Pubmed

ERbeta1 represses basal breast cancer epithelial to mesenchymal transition by destabilizing EGFR.

CBL EGFR

6.77e-053166223158001
Pubmed

Metastasis suppressor tetraspanin CD82/KAI1 regulates ubiquitylation of epidermal growth factor receptor.

CBL EGFR

6.77e-053166223897813
Cytoband10q22-q23

BTAF1 POLR3A

1.29e-045166210q22-q23
CytobandEnsembl 112 genes in cytogenetic band chr9q12

SPATA31A7 SPATA31A5

3.59e-0481662chr9q12
CoexpressionLAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP

IPO5 KIF18A PHF19 STRBP HNRNPA3 SYT9 HMMR DDX11 GREB1L FOXRED2 BRCA2 RALGPS1 NEIL3 CLSPN TUBE1 FIGNL1 DDX11L8

1.51e-0668016517MM456
CoexpressionHAMAI_APOPTOSIS_VIA_TRAIL_UP

IPO5 KIF18A CWF19L2 ZBTB38 GPBP1 BAZ2B ZNF268 ORC3 STRBP HMMR ITGB3BP RPS6KC1 RESF1 SLC30A5 GKAP1 DHX29

4.27e-0665616516M18979
CoexpressionGSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP

HNRNPA3 HMMR BRCA2 NEIL3 CLSPN TUBE1 FIGNL1 HDLBP

2.55e-051871658M2984
CoexpressionMILI_PSEUDOPODIA_HAPTOTAXIS_UP

ZBTB38 GPBP1 ORC3 STRBP VPS4B HNRNPA3 TRMT11 TOGARAM1 OLA1 ITGB3BP BCLAF3 SNX6 GKAP1

2.89e-0552316513M12707
CoexpressionMILI_PSEUDOPODIA_HAPTOTAXIS_UP

ZBTB38 GPBP1 ORC3 STRBP VPS4B HNRNPA3 TRMT11 TOGARAM1 OLA1 ITGB3BP BCLAF3 SNX6 GKAP1

3.58e-0553416513MM1054
CoexpressionGSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_6H_UP

ERCC3 APOB NUDCD3 GDF2 ARFIP1 NPHP4 GREB1L BRD2

3.70e-051971658M8159
CoexpressionGSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_DN

ARFIP1 HIRA DDX11 FOXRED2 NEIL3 DCLRE1A TRMT61B IMMT

3.70e-051971658M7683
CoexpressionGSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_DN

ZC3H14 TAGAP BAZ2B STRBP HNRNPA3 TRMT11 BTAF1 TUBE1

4.12e-052001658M5081
CoexpressionGSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_DN

ABCA1 TTPAL TKTL1 SLC30A5 GIMAP8 BAIAP2L1 TRAM1 RALGPS1

4.12e-052001658M8956
ToppCellLPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

KIF18A PHF19 HMMR GALNT18 ITGB3BP DDX11 UBE2T BRCA2 NEIL3 CLSPN

1.58e-0918016610334e2b1f6eb7d4ece20b1c7b02107863f913237f
ToppCell367C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

OLAH PHF19 DAB1 TKTL1 GALNT18 UBE2T BRCA2 NEIL3 CLSPN

2.08e-0817516690b1aaa028ba844d4bcb4509fdab8bee648373935
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

KIF18A PHF19 ZNF165 HMMR ITGB3BP UBE2T BRCA2 NEIL3 CLSPN

6.28e-0819916694af38f5e9d2229d64f7ecdf9c00b4d67e5f86a51
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW19-Stem_cells|GW19 / Sample Type, Dataset, Time_group, and Cell type.

KIF18A PHF19 TRMT11 TKTL1 HMMR ITGB3BP BRCA2 NEIL3 CLSPN

6.56e-08200166931dd81df9aa754a1e69b905bf9b8ce73ff8175aa
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW19-Stem_cells-Neuroepithelial_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type.

KIF18A PHF19 TRMT11 TKTL1 HMMR ITGB3BP BRCA2 NEIL3 CLSPN

6.56e-08200166954174a485a82480726fa06efa6e050ddea77cb3c
ToppCellGlobus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

PHF19 HMMR DDX11 UBE2T MAP4K1 NEIL3 CLSPN FIGNL1

1.69e-0716116680dd1401b4c990d49fccb702a9f9867590a58e203
ToppCellGlobus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1-Mitotic.MkI67_(Mitotic.MkI67)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

PHF19 HMMR DDX11 UBE2T MAP4K1 NEIL3 CLSPN FIGNL1

1.69e-071611668b6a31c033edc74f23a20aab1f18e80cc83ffee4c
ToppCellGlobus_pallidus-Macroglia-POLYDENDROCYTE-P5|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

PHF19 HMMR DDX11 UBE2T MAP4K1 NEIL3 CLSPN FIGNL1

1.69e-071611668efb811dda4d73107983a5f68302bdcf4f408d5b4
ToppCellGlobus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1-Mitotic.MkI67_(Mitotic.MkI67)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

PHF19 HMMR DDX11 UBE2T MAP4K1 NEIL3 CLSPN FIGNL1

1.69e-07161166828d5dbd20c9f8e0069f172d552997a044790e1a7
ToppCellLPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

KIF18A PHF19 HMMR DDX11 PTPRB BRCA2 NEIL3 CLSPN

1.85e-0716316685285318c52aa31c9b22dc2ffff078e32e408604d
ToppCell367C-Lymphocytic-NK_cells-Proliferating_NK_cell|367C / Donor, Lineage, Cell class and subclass (all cells)

PHF19 STRBP DAB1 TKTL1 UBE2T BRCA2 NEIL3 CLSPN

2.67e-0717116684ede6e916e593f208f2f8ccf82ef2335e061fc86
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

KIF18A ZNF165 HMMR ZNF385D UBE2T BRCA2 NEIL3 CLSPN

3.19e-071751668876cea684faf42ff3eb4623ad6d7a1fb1276ee02
ToppCellPBMC-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters

IPO5 ZNF132 PSAT1 HIP1R ABCC11 MECOM POGLUT2 CLSPN

5.72e-071891668946c95d2ecc36b241f58e8c4ad6455fe47c762fa
ToppCellControl-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

KIF18A PHF19 HMMR DDX11 UBE2T BRCA2 NEIL3 CLSPN

5.72e-0718916681e1499b062d9c647c8f38b0c4e0d871d159be5dd
ToppCellMild-T/NK_proliferative|World / Disease group and Cell class

KIF18A HMMR ITGB3BP DDX11 UBE2T BRCA2 NEIL3 CLSPN

6.19e-0719116689dba5526fd5ea8065ad305feb2ee562335f887c6
ToppCell367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|367C / Donor, Lineage, Cell class and subclass (all cells)

KIF18A PHF19 HMMR UBE2T BRCA2 LPL NEIL3 CLSPN

6.97e-071941668a12b64945e10f00aa983678a02586c59badc1570
ToppCell367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

KIF18A PHF19 HMMR DDX11 UBE2T BRCA2 NEIL3 CLSPN

7.53e-0719616689591a6a3477ed6a1e2e016f7542e38603d8b16cb
ToppCellsevere-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

KIF18A PHF19 HMMR YWHAE UBE2T BRCA2 NEIL3 CLSPN

8.12e-0719816684d8591eabb543ed789f963b507a07c560c76a7c9
ToppCellcycling_basal_cell|World / shred by cell class for turbinate

KIF18A PHF19 HMMR ITGB3BP UBE2T BRCA2 NEIL3 CLSPN

8.12e-071981668e86c1224f5b0890a50a25257628e90c790aae7cd
ToppCellMNPs-Dividing_Macrophages|MNPs / lung cells shred on cell class, cell subclass, sample id

KIF18A PHF19 HMMR ITGB3BP UBE2T BRCA2 NEIL3 CLSPN

8.44e-0719916685952980d0ece5d73f3e9f340c56a38b34d2f2309
ToppCellBrain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells-Neuroepithelial_cell|10w / Sample Type, Dataset, Time_group, and Cell type.

KIF18A PHF19 HMMR ITGB3BP UBE2T BRCA2 NEIL3 CLSPN

8.76e-0720016688f8b8c225cdc79baf16fe04be89bdb65e404a055
ToppCellBrain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells|10w / Sample Type, Dataset, Time_group, and Cell type.

KIF18A PHF19 HMMR ITGB3BP UBE2T BRCA2 NEIL3 CLSPN

8.76e-072001668a1f48eca9efb4f3ec3c9ace20f8c9257dd72c4ed
ToppCellControl_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type

KIF18A PHF19 HMMR DDX11 UBE2T BRCA2 NEIL3 CLSPN

8.76e-0720016689bbc7b5561151f6ff65f40b3226271def732e5d9
ToppCellBrain_organoid-organoid_Tanaka_cellReport-5w-Stem_cells-Neuroepithelial_cell|5w / Sample Type, Dataset, Time_group, and Cell type.

KIF18A PSAT1 PHF19 HMMR UBE2T BRCA2 NEIL3 CLSPN

8.76e-072001668c865efaaaecccbf9c833d6c1cbe85809a3ec306d
ToppCellTCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic|TCGA-Bile_Duct / Sample_Type by Project: Shred V9

GPBP1 HIP1R NSD1 GALNT18 POLR3A SLC30A5 SPATS2 DHX29

8.76e-0720016681fa8422fd820d21e285a7e7c4c6fbd8b7277d2af
ToppCellNS-moderate-d_07-13-Lymphoid-NKT-proliferating|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

KIF18A PHF19 HMMR ITGB3BP UBE2T BRCA2 NEIL3 CLSPN

8.76e-07200166887e293c0882e2754756a2210a6c04723dc89f81b
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

KIF18A PHF19 HMMR ITGB3BP UBE2T BRCA2 NEIL3 CLSPN

8.76e-07200166828c702449040ac15fe4e0c6340bb6f137e88539d
ToppCellBrain_organoid-organoid_Tanaka_cellReport-5w-Stem_cells|5w / Sample Type, Dataset, Time_group, and Cell type.

KIF18A PSAT1 PHF19 HMMR UBE2T BRCA2 NEIL3 CLSPN

8.76e-0720016682ee167b8bddd11fd5b1f61f87fcdf757aee3193e
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW26-Stem_cells-Neuroepithelial_cell|GW26 / Sample Type, Dataset, Time_group, and Cell type.

KIF18A PHF19 HMMR ITGB3BP UBE2T BRCA2 NEIL3 CLSPN

8.76e-072001668203b9a5de4430713da01b3331e69381db449a3a0
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW26-Stem_cells|GW26 / Sample Type, Dataset, Time_group, and Cell type.

KIF18A PHF19 HMMR ITGB3BP UBE2T BRCA2 NEIL3 CLSPN

8.76e-072001668a854e19703dc920e48304541e2b06ed013292f3e
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

KIF18A PHF19 HMMR UBE2T BRCA2 NEIL3 CLSPN

2.01e-061561667b3f10cd044f24807576e7d56e51df7064dbf6c50
ToppCelldroplet-Lung-nan-3m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HMMR ITGB3BP DDX11 UBE2T NEIL3 DCLRE1A FIGNL1

2.19e-061581667ee8ce3cd202807df692b28bb1a81827d49d73862
ToppCelldroplet-Heart-nan-24m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HMMR GMEB2 MADD PLEKHH1 BRCA2 NEIL3 CLSPN

3.16e-061671667bad33497ceeab968a7eb8a48b921c6f936390743
ToppCellLPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

KIF18A HMMR DDX11 UBE2T BRCA2 NEIL3 CLSPN

3.42e-061691667e0607af8ae8609d43e26ff2a2cab92650bfcd5b7
ToppCellE18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

KIF18A HMMR UBE2T DACT3 KCNQ3 NEIL3 CLSPN

3.84e-061721667c06ca5d075937747952ed915c9db39a9f62072f9
ToppCellMild/Remission-B_naive-8|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)

GPBP1 CRIM1 TAGAP BAZ2B HIP1R PARP14 ZBTB10

3.99e-061731667694d02c4d2dc2de4b344544f9124fec40fcf7d8f
ToppCell367C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

PHF19 HMMR PLEKHH1 UBE2T BRCA2 MAP4K1 CLSPN

4.31e-0617516676b4e841bde6cfa4956e1a0231672cea20f11210c
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

KIF18A HMMR ZNF385D UBE2T BRCA2 NEIL3 CLSPN

5.18e-061801667401df9cddcbca1eb8f0d2687bcacd98e95dc1493
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

MECOM CD46 SCEL GALNT18 TKT ATP2C2 KCNQ3

5.37e-061811667576da14ab3107f89e1f44a4a439d1bef5bb42370
ToppCellPND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PDK4 HMMR SCEL LPL MMP12 TUBE1 RUFY4

5.57e-06182166721dcab170ffeef89faa9fee5008568cb6e15c694
ToppCellTCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5|TCGA-Liver / Sample_Type by Project: Shred V9

KIF18A HMMR ITGB3BP BRCA2 NEIL3 SPATS2 CLSPN

5.78e-061831667f604a8b62c7088fad8365dbf8d910fc980bd3ba8
ToppCell367C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells)

OLAH PHF19 HMMR UBE2T BRCA2 NEIL3 CLSPN

5.78e-061831667a716b446c2bf5aa294b8f580aa845098fae76354
ToppCellCerebellum-Macroglia-ASTROCYTE-Gja1-Gfap-_astrocytes_(Htra1)-|Cerebellum / BrainAtlas - Mouse McCarroll V32

KIF18A HMMR ATP2C2 TNNT3 SDS

5.98e-0669166554e5ede00ce2920158d1cc0ac8e718aa24a4342e
ToppCellCerebellum-Macroglia-ASTROCYTE-Gja1-Gfap-_astrocytes_(Htra1)|Cerebellum / BrainAtlas - Mouse McCarroll V32

KIF18A HMMR ATP2C2 TNNT3 SDS

5.98e-06691665c93a47ee777b560f69b705d5d597f3cb3a3f558a
ToppCellCerebellum-Macroglia-ASTROCYTE-Gja1-Gfap-_astrocytes_(Htra1)--|Cerebellum / BrainAtlas - Mouse McCarroll V32

KIF18A HMMR ATP2C2 TNNT3 SDS

5.98e-066916658946d7e433c232c56563a6c464152c0a8cdbdf92
ToppCellDividing_Macrophages-IPF_01|World / lung cells shred on cell class, cell subclass, sample id

PCDHGC5 PHF19 HMMR UBE2T BRCA2 NEIL3 CLSPN

5.99e-061841667f15ce786d25c6546804a6d1efcc2ad645f2ef54e
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

PSAT1 PHF19 HMMR ITGB3BP UBE2T POGLUT2 CLSPN

5.99e-061841667a0831e850bc0b585296ed350fdd075c1f730308e
ToppCelldroplet-Lung-3m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

HMMR DDX11 UBE2T NEIL3 DCLRE1A CLSPN FIGNL1

6.89e-0618816670ec2a1b0505501ba18f10a5fce68c306a6292419
ToppCellNS-critical-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

KIF18A PSAT1 HMMR UBE2T BRCA2 TRMT61B CLSPN

7.13e-061891667d6bd46abb072b13a6b72f1ca25d19f218cceb1ff
ToppCellfacs-Skin-Anagen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KIF18A HMMR UBE2T DHRS7C NEIL3 CLSPN FIGNL1

7.13e-061891667bfa3ed1360991a3e32fad133017c413f8adc1eba
ToppCellfacs-Skin-Anagen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KIF18A HMMR UBE2T DHRS7C NEIL3 CLSPN FIGNL1

7.13e-06189166796f10c63656e446b4bb712f012e91ae986f8c2d0
ToppCell3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PHF19 HMMR ITGB3BP UBE2T BRCA2 NEIL3 CLSPN

7.38e-061901667b69940d16685249167d4c2cf6ad8237ccf6f7590
ToppCell5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

KIF18A PHF19 HMMR HNRNPA2B1 ITGB3BP UBE2T NEIL3

7.38e-061901667cd37ccd30c27cf65eda0a9165f35b7672f5acaf6
ToppCelldroplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PHF19 HMMR UBE2T NEIL3 CLSPN TUBE1 FIGNL1

7.64e-06191166715dbc5a03bfab8931c0fd385b0f25874736ae874
ToppCellkidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PHF19 HMMR UBE2T BRCA2 MAP4K1 NEIL3 CLSPN

7.64e-061911667ff2cc4c10aa584b3daeaaf23cd8ee09bdbdf684d
ToppCelldroplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PHF19 HMMR UBE2T NEIL3 CLSPN TUBE1 FIGNL1

7.64e-06191166745c15f5ce4a207ac944bed65d45f06c1657d1a6d
ToppCelltumor_Lymph_Node_/_Brain-T/NK_cells-Undetermined|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass

PHF19 HMMR ITGB3BP UBE2T MAP4K1 NEIL3 CLSPN

7.90e-0619216673856c4d611224cd6c2558631147cd5333bc0ccb7
ToppCellControl-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class

KIF18A PHF19 HMMR UBE2T BRCA2 NEIL3 CLSPN

8.18e-06193166733d409d6ed1c606337248587ad997ac5f67f081d
ToppCellhuman_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

KIF18A ORC3 HMMR ITGB3BP DDX11 BRCA2 CLSPN

8.18e-0619316674b9fa2a4424f8abe63fa7bee78db93dda04ab15f
ToppCell5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PHF19 HMMR UBE2T BRCA2 LPL NEIL3 CLSPN

8.46e-061941667e5b81a8e52259a54a911c1c2ac932c98c988318d
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

KIF18A PHF19 HMMR UBE2T BRCA2 NEIL3 CLSPN

8.46e-0619416671a2090e997c70433d07f56bf7cb0a50c4151118c
ToppCellControl-Lymphocyte-T_NK-T_NK_proliferative|Control / Disease, Lineage and Cell Type

KIF18A PHF19 HMMR UBE2T BRCA2 NEIL3 CLSPN

8.46e-061941667844731b7943d1cfca819b7b89e4e62067bfa0230
ToppCell390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells)

ABCA1 LRRC37A2 GSDMB SCEL PARP14 BCLAF3 ATP2C2

8.46e-06194166788db9f9e80c20ff3474f1f6459dcbdc25aec0b6d
ToppCell390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells)

ABCA1 LRRC37A2 GSDMB SCEL PARP14 BCLAF3 ATP2C2

8.46e-061941667a71728202493d4858342ea2756ea281cd0d99a3a
ToppCell(1)_T_cells-(1)_T_cells_Dividing|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)

PHF19 HMMR ITGB3BP DDX11 UBE2T BRCA2 CLSPN

8.74e-061951667cf00a0b4f341f0487d5b37810abe2952fdd3f6f2
ToppCellPCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

KIF18A HMMR ITGB3BP UBE2T BRCA2 NEIL3 CLSPN

9.04e-06196166773f951f7712e0aa3323676b9a4b7944d21d347c4
ToppCell(3)_MNP-(3)_Macrophage_Dividing|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4)

KIF18A PHF19 HMMR ITGB3BP UBE2T NEIL3 CLSPN

9.35e-061971667048bc4f8fd5d4f394e2384700640f72042336597
ToppCellInfluenza-Influenza_Severe-Lymphocyte-B-Plasmablast|Influenza_Severe / Disease, condition lineage and cell class

KIF18A PSAT1 GALNT18 UBE2T TXNL4B ATP6V1C2 POGLUT2

9.35e-0619716679108edafbf5744ed65f556bcbbf819a9b71176a9
ToppCellmild-Plasmablast|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

PSAT1 HMMR COL24A1 BRCA2 SETBP1 SPATS2 HDLBP

9.35e-06197166721085d5e27b5a23a241a933058bb89f8a1fcf198
ToppCellsevere_COVID-19-T/NK_proliferative|severe_COVID-19 / disease group, cell group and cell class (v2)

PSAT1 PHF19 HMMR DDX11 UBE2T BRCA2 CLSPN

9.66e-061981667ed86b0247006befe55400c287d334d2202b470bd
ToppCell(0)_NK_cells-(0)_NK_Dividing|(0)_NK_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)

PHF19 HMMR ITGB3BP UBE2T BRCA2 NEIL3 CLSPN

9.66e-061981667d9cdbc7d420472cb1ffb36ad9c8e53a61b7dbdeb
ToppCellCOVID-19_Moderate-T/NK_proliferative|World / disease group, cell group and cell class

PHF19 HMMR DDX11 UBE2T BRCA2 NEIL3 CLSPN

9.66e-061981667bf0131fbca6032e1aab4aa807f8c1d3be689cb7f
ToppCell356C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells)

KIF18A PHF19 HMMR ITGB3BP UBE2T NEIL3 CLSPN

9.66e-0619816676a10bb81817ab606f1f5a2bd8cfe77ef2fb3f2fb
ToppCellmedial-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

KIF18A PHF19 HMMR UBE2T BRCA2 NEIL3 CLSPN

9.66e-06198166764a2bcf5a9ba66a4fe08fbde33f1886c136cde8f
ToppCellmedial-Hematologic-Proliferating_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

KIF18A PHF19 HMMR UBE2T BRCA2 NEIL3 CLSPN

9.66e-061981667fcc14ac3eb5088b9d6cd6af5a34dee5b81c0ece8
ToppCelldistal-Hematologic-Proliferating_Macrophage-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

KIF18A PHF19 HMMR UBE2T BRCA2 NEIL3 CLSPN

9.66e-0619816678afeb1f9bc9d8551482c8fefe4c5f88d9cd13ee2
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

KIF18A HMMR ITGB3BP DDX11 UBE2T BRCA2 CLSPN

9.66e-0619816676981cd5b1585c8ae6febdf0c4fb83067127f106c
ToppCellBrain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating-cycling_dorsal_progenitors|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.

KIF18A PHF19 HMMR UBE2T BRCA2 NEIL3 CLSPN

9.66e-061981667dada1c19a261c8e1090957cd7e37f2a43a9fe14f
ToppCellmedial-Hematologic-Proliferating_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

KIF18A PHF19 HMMR UBE2T BRCA2 NEIL3 CLSPN

9.66e-061981667da6963184c32761c896a9b91a5321ad84b583736
ToppCellCOVID-19-Lymphoid-Proliferating_CD4_T_cells|Lymphoid / Condition, Lineage and Cell class

PHF19 HMMR ITGB3BP UBE2T BRCA2 NEIL3 CLSPN

9.98e-0619916672e9ee10a069afca5dbd9f0863cf90a66db1a6ffb
ToppCellBrain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating-Cycling_Progenitors|6_mon / Sample Type, Dataset, Time_group, and Cell type.

KIF18A PHF19 HMMR UBE2T BRCA2 NEIL3 CLSPN

9.98e-061991667a99516a5760f49a69b0fe45a9b2316e393252966
ToppCellCOVID-19-Lymphoid-Proliferating_CD4_T_cells|COVID-19 / Condition, Lineage and Cell class

KIF18A PHF19 HMMR ITGB3BP UBE2T NEIL3 CLSPN

9.98e-061991667e1dfc856a85a91e8f7ab8d600a8a891d16b2aefb
ToppCell367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Macrophage / Donor, Lineage, Cell class and subclass (all cells)

KIF18A PHF19 HMMR UBE2T BRCA2 NEIL3 CLSPN

9.98e-06199166788d130e2451e61afb710edf552e6b346b9fcfb2b
ToppCellBrain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_IN_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type.

KIF18A PHF19 HMMR UBE2T BRCA2 NEIL3 CLSPN

9.98e-061991667f315ec3fb6c0799668c9195f836a77fc0db2b615
ToppCellTCGA-Stomach-Primary_Tumor|TCGA-Stomach / Sample_Type by Project: Shred V9

KIF18A HMMR HNRNPA2B1 KNOP1 UBE2T CLSPN NOP2

9.98e-06199166738f1f612b29feb868322999ceeda78e52447ec4f
ToppCellDividing_Macrophages|World / lung cells shred on cell class, cell subclass, sample id

PHF19 HMMR ITGB3BP UBE2T BRCA2 NEIL3 CLSPN

9.98e-0619916675c755b6876e164dc847ef7c723f850f227cf3a87
ToppCellLPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

KIF18A HMMR DDX11 UBE2T BRCA2 NEIL3 CLSPN

9.98e-061991667be2276c9a1994579ba1d2998b49bf549c1324d44
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

PSAT1 HMMR ITGB3BP DDX11 UBE2T BRCA2 CLSPN

9.98e-061991667616c04b0605907fb218263f2164c36cb2fa26b87
ToppCellBrain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors_nGenesUnder4k|3.5_mon / Sample Type, Dataset, Time_group, and Cell type.

KIF18A PHF19 HMMR UBE2T BRCA2 NEIL3 CLSPN

9.98e-0619916672fbf94f7858250088e0f5ce1ff51892730a13ae8
ToppCellMild-T/NK_proliferative|Mild / Disease group and Cell class

KIF18A PHF19 HMMR UBE2T BRCA2 NEIL3 CLSPN

9.98e-06199166764a5c91243ee999ea21ffddd450d3e5fdbf6470b
ToppCell(1)_T_cells-(1)_T_cell_dividing|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)

KIF18A PHF19 HMMR UBE2T BRCA2 NEIL3 CLSPN

9.98e-06199166733afdd1b1b951b360ababf440bc556fd9e1c1db2
ToppCellTCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma|TCGA-Stomach / Sample_Type by Project: Shred V9

KIF18A HMMR HNRNPA2B1 KNOP1 UBE2T CLSPN NOP2

9.98e-061991667b10698aee2e6c17bc559eb4f723024141f914b90
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type.

PHF19 GMEB2 ITGB3BP NBAS BRCA2 SPATS2 CLSPN

1.03e-052001667d933978b55fefe52cad599b36f6b47a0c7f71f96
ToppCellLPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

KIF18A HMMR DDX11 UBE2T BRCA2 NEIL3 CLSPN

1.03e-0520016674cfe08878a6981bf7b3567f9e82192d8f060ddde
ToppCelldistal-Hematologic-Proliferating_Macrophage|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

KIF18A PHF19 HMMR UBE2T BRCA2 NEIL3 CLSPN

1.03e-0520016673835a8a9739b8cd5bf19c40765ef76907ac1ad38
ToppCellBrain_organoid-organoid_Tanaka_cellReport-3m-Stem_cells-Neuroepithelial_cell|3m / Sample Type, Dataset, Time_group, and Cell type.

KIF18A PHF19 HMMR UBE2T BRCA2 NEIL3 CLSPN

1.03e-0520016672938a029fa0478be561574ace91f95c4a528b2d4
ToppCelldistal-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

KIF18A PHF19 HMMR UBE2T BRCA2 NEIL3 CLSPN

1.03e-0520016670cd3b01fb7f579e5abf000adb8ec8adc7cd779c4
ToppCellBAL-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

KIF18A PHF19 HMMR ITGB3BP UBE2T NEIL3 CLSPN

1.03e-052001667535f6fba8d03873ba35c9949579161dc41cd7a60
ToppCellSevere_COVID-19-T/NK-proliferating_T/NK|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30)

KIF18A PHF19 HMMR ITGB3BP UBE2T NEIL3 CLSPN

1.03e-05200166752265e761a961f3724b388285e0919bd58847138
ToppCell356C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells)

PHF19 HMMR ITGB3BP UBE2T BRCA2 NEIL3 CLSPN

1.03e-05200166797e47eb69d1d4cab45256acca9589837eb7817e7
DiseaseMalignant neoplasm of breast

TPTE FLNA ERCC3 STRBP LRRC37A2 GSDMB TRMT11 MECOM HMMR OLA1 BMP4 SETD2 LRRC37A BRCA2 EGFR SETBP1 GALNT5 CLSPN HDLBP

4.31e-06107415619C0006142
Diseasemyopathy (implicated_via_orthology)

FLNA MYH3 FLNC HNRNPA3 HNRNPA2B1

5.52e-06481565DOID:423 (implicated_via_orthology)
Diseasedistal arthrogryposis type 2B (is_implicated_in)

MYH3 TNNT3

2.78e-0521562DOID:0111599 (is_implicated_in)
DiseaseMYELODYSPLASTIC SYNDROME

MECOM CBL UBE2T BRCA2 SETBP1

2.87e-05671565C3463824
DiseaseHyperlipoproteinemia Type IIb

ABCA1 APOB LPL

3.99e-05131563C1704417
DiseaseHyperlipoproteinemia Type IIa

ABCA1 APOB LPL

7.72e-05161563C0745103
Diseasetriglycerides in large LDL measurement

ABCA1 APOB TXNL4B LPL

7.90e-05431564EFO_0022319
Diseasemyofibrillar myopathy 5 (implicated_via_orthology)

FLNA FLNC

8.30e-0531562DOID:0080096 (implicated_via_orthology)
Diseasedistal muscular dystrophy 4 (implicated_via_orthology)

FLNA FLNC

8.30e-0531562DOID:0111190 (implicated_via_orthology)
DiseaseWarsaw breakage syndrome (implicated_via_orthology)

DDX11 DDX11L8

8.30e-0531562DOID:0060535 (implicated_via_orthology)
DiseaseHypercholesterolemia, Familial

ABCA1 APOB LPL

1.12e-04181563C0020445
DiseaseMammary Carcinoma, Human

FLNA LRRC37A2 TRMT11 MECOM HMMR BMP4 SETD2 LRRC37A BRCA2 EGFR SETBP1

1.17e-0452515611C4704874
DiseaseMammary Neoplasms, Human

FLNA LRRC37A2 TRMT11 MECOM HMMR BMP4 SETD2 LRRC37A BRCA2 EGFR SETBP1

1.17e-0452515611C1257931
DiseaseMammary Neoplasms

FLNA LRRC37A2 TRMT11 MECOM HMMR BMP4 SETD2 LRRC37A BRCA2 EGFR SETBP1

1.21e-0452715611C1458155
DiseaseBreast Carcinoma

FLNA LRRC37A2 TRMT11 MECOM HMMR BMP4 SETD2 LRRC37A BRCA2 EGFR SETBP1

1.44e-0453815611C0678222
Diseasefree cholesterol in large LDL measurement

ABCA1 APOB TXNL4B LPL

1.55e-04511564EFO_0022176
DiseaseSheldon-Hall syndrome

MYH3 TNNT3

1.65e-0441562cv:C1834523
DiseaseNoonan syndrome (implicated_via_orthology)

APAF1 CBL

1.65e-0441562DOID:3490 (implicated_via_orthology)
DiseaseSotos' syndrome

NSD1 SETD2

1.65e-0441562C0175695
Diseasetuberous sclerosis (is_marker_for)

FLNA BMP4

1.65e-0441562DOID:13515 (is_marker_for)
Diseasecolorectal cancer (is_marker_for)

KIF18A ERCC3 CBL SETD2 BRCA2 EGFR

1.94e-041571566DOID:9256 (is_marker_for)
Diseasetriglycerides in LDL measurement

ABCA1 APOB TXNL4B LPL

2.23e-04561564EFO_0022320
DiseaseMalignant Cystosarcoma Phyllodes

FLNA SETD2

2.75e-0451562C0600066
DiseasePhyllodes Tumor

FLNA SETD2

2.75e-0451562C0010701
DiseaseMyelomonocytic leukemia

CBL SETBP1

2.75e-0451562C0027019
Diseasefree cholesterol to total lipids in medium HDL percentage

ABCA1 APOB MADD LPL

2.91e-04601564EFO_0022282
Diseasehigh density lipoprotein particle size measurement

ABCA1 APOB MADD BAIAP2L1 LPL HDLBP

2.98e-041701566EFO_0008592
Diseasephospholipid measurement, high density lipoprotein cholesterol measurement

ABCA1 ZBTB38 APOB MADD BAIAP2L1 TXNL4B LPL HDLBP

3.24e-043211568EFO_0004612, EFO_0004639
DiseaseLeukemia, Myelocytic, Acute

NSD1 MECOM CBL SETD2 UBE2T SETBP1

3.27e-041731566C0023467
Diseasetriglycerides in medium LDL measurement

ABCA1 APOB TXNL4B LPL

3.30e-04621564EFO_0022322
Diseaselow density lipoprotein cholesterol measurement, lipid measurement

ABCA1 APOB BRCA2 TXNL4B LPL

3.58e-041141565EFO_0004529, EFO_0004611
DiseaseDigitotalar Dysmorphism

MYH3 TNNT3

4.11e-0461562C1852085
DiseaseARTHROGRYPOSIS, DISTAL, TYPE 1

MYH3 TNNT3

4.11e-0461562C0220662
DiseaseARTHROGRYPOSIS, DISTAL, TYPE 2B

MYH3 TNNT3

4.11e-0461562C1834523
Diseasetotal lipids in very large HDL measurement

ABCA1 APOB MADD LPL

4.20e-04661564EFO_0022312
Diseasephospholipids:total lipids ratio, intermediate density lipoprotein measurement

ABCA1 APOB TXNL4B LPL

4.45e-04671564EFO_0008595, EFO_0020946
DiseaseMiller Dieker syndrome

YWHAE UBE2T BRCA2

4.79e-04291563C0265219
Diseasecholesterol in very large HDL measurement

ABCA1 APOB MADD LPL

4.97e-04691564EFO_0022229
DiseaseHMG CoA reductase inhibitor use measurement

ABCA1 APOB SETD2 BRCA2 TXNL4B LPL

5.23e-041891566EFO_0009932
Diseasecholesteryl ester measurement, low density lipoprotein cholesterol measurement

ABCA1 APOB BRCA2 TXNL4B LPL

5.66e-041261565EFO_0004611, EFO_0010351
Diseasemyeloid neoplasm (is_implicated_in)

MECOM CBL

5.73e-0471562DOID:0070004 (is_implicated_in)
Diseasecholesteryl esters to total lipids in large LDL percentage

ABCA1 APOB LPL

5.84e-04311563EFO_0022249
Diseasetotal lipids in large HDL

ABCA1 APOB MADD LPL

6.49e-04741564EFO_0022189
Diseasefamilial hyperlipidemia (is_implicated_in)

APOB LPL

7.62e-0481562DOID:1168 (is_implicated_in)
DiseaseUnilateral agenesis of kidney

GREB1L BMP4

7.62e-0481562C0266294
DiseaseAdenocarcinoma of lung (disorder)

IPO5 PSAT1 STRBP RPS6KC1 EGFR FGFR4

8.21e-042061566C0152013
Diseasefree cholesterol in large HDL measurement

ABCA1 APOB MADD LPL

8.30e-04791564EFO_0022157
DiseaseSchizophrenia

IPO5 IL10RA DLGAP1 PSAT1 ABCA1 LAMA1 HNRNPA3 YWHAE FBXL21P EGR3 LPL KCNQ3 HAGH

8.65e-0488315613C0036341
Diseasecholesterol in large HDL measurement

ABCA1 APOB MADD LPL

8.70e-04801564EFO_0021900
Diseaselung non-small cell carcinoma (is_implicated_in)

ERCC3 CBL PTPRB EGFR FGFR4

8.82e-041391565DOID:3908 (is_implicated_in)
DiseaseDistal arthrogryposis

MYH3 TNNT3

9.76e-0491562cv:C0265213
Disease22q11 partial monosomy syndrome

RREB1 HIRA

9.76e-0491562C3266101
DiseaseCancer of Nasopharynx

MECOM EGFR

9.76e-0491562C0238301
DiseaseNasopharyngeal Neoplasms

MECOM EGFR

9.76e-0491562C0027439
Diseasecholesteryl esters to total lipids in medium LDL percentage

APOB TXNL4B LPL

9.87e-04371563EFO_0022252
Diseasehepatocellular carcinoma (is_marker_for)

ABCA1 CBL HNRNPA2B1 PTPRB EGFR NEIL3 FGFR4

1.14e-033011567DOID:684 (is_marker_for)
DiseaseHypercholesterolemia

ABCA1 APOB LPL

1.15e-03391563C0020443
DiseaseAsymmetric crying face association

RREB1 HIRA

1.22e-03101562C0431406
Diseaselevel of Triacylglycerol (51:3) in blood serum

APOB LPL

1.22e-03101562OBA_2045163
Disease22q11 Deletion Syndrome

RREB1 HIRA

1.22e-03101562C2936346
Diseaseciliopathy (implicated_via_orthology)

TOGARAM1 NPHP4 MAP4K1

1.24e-03401563DOID:0060340 (implicated_via_orthology)
Diseasephospholipids:total lipids ratio, high density lipoprotein cholesterol measurement

ABCA1 APOB MADD BAIAP2L1 TXNL4B LPL HDLBP

1.28e-033071567EFO_0004612, EFO_0020946
DiseaseColonic Neoplasms

TRMT11 MECOM EGFR LPL MMP12

1.31e-031521565C0009375
Diseaseosteosarcoma (is_marker_for)

CBL PTPRB

1.48e-03111562DOID:3347 (is_marker_for)
Diseasecholesteryl ester measurement, intermediate density lipoprotein measurement

ABCA1 APOB TXNL4B LPL

1.58e-03941564EFO_0008595, EFO_0010351
DiseaseMalignant tumor of colon

TRMT11 MECOM EGFR LPL MMP12

1.60e-031591565C0007102
Diseaselipid measurement, intermediate density lipoprotein measurement

ABCA1 APOB TXNL4B LPL

1.71e-03961564EFO_0004529, EFO_0008595
Diseasetotal lipids in very small VLDL measurement

APOB TXNL4B LPL

1.75e-03451563EFO_0022156
DiseaseQRS complex, QRS duration

CRIM1 TKT SETBP1

1.75e-03451563EFO_0005054, EFO_0005055
DiseaseMalignant neoplasm of kidney

UBE2T BRCA2 FIGNL1

1.75e-03451563C0740457
Diseasesaturated fatty acids measurement

ABCA1 APOB LPL

1.75e-03451563EFO_0022304
Diseasepeptic esophagitis (biomarker_via_orthology)

BMP4 EGFR

1.77e-03121562DOID:13976 (biomarker_via_orthology)
DiseaseRenal dysplasia and retinal aplasia (disorder)

NPHP4 POC1B

1.77e-03121562C0403553
Diseaseintegral membrane protein 2B measurement

APOB LPL

1.77e-03121562EFO_0802634
Diseasetotal cholesterol measurement, intermediate density lipoprotein measurement

ABCA1 APOB TXNL4B LPL

1.92e-03991564EFO_0004574, EFO_0008595
Diseaselipid measurement, high density lipoprotein cholesterol measurement

ABCA1 ZBTB38 APOB MADD BAIAP2L1 LPL HDLBP

1.93e-033301567EFO_0004529, EFO_0004612
Diseasetriglyceride measurement, low density lipoprotein cholesterol measurement

ABCA1 APOB BRCA2 TXNL4B LPL

1.93e-031661565EFO_0004530, EFO_0004611
DiseaseCeliac Disease

APOB LPL MMP12

1.98e-03471563C0007570
Diseasefree cholesterol in small VLDL measurement

APOB TXNL4B LPL

1.98e-03471563EFO_0022272
Diseasefree cholesterol in very small VLDL measurement

APOB TXNL4B LPL

1.98e-03471563EFO_0022275
Diseasefree cholesterol in medium VLDL measurement

APOB TXNL4B LPL

1.98e-03471563EFO_0022269
Diseasecoronary artery disease (is_implicated_in)

ABCA1 APOB LPL MMP12

1.99e-031001564DOID:3393 (is_implicated_in)
Diseasetriglyceride measurement, alcohol consumption measurement

ABCA1 APOB TXNL4B LPL

2.06e-031011564EFO_0004530, EFO_0007878
Diseaselung non-small cell carcinoma (is_marker_for)

APAF1 HNRNPA2B1 PTPRB EGFR FGFR4

2.09e-031691565DOID:3908 (is_marker_for)
Diseaselung adenocarcinoma (is_implicated_in)

SETD2 EGFR FGFR4

2.23e-03491563DOID:3910 (is_implicated_in)
Diseaseapolipoprotein B to apolipoprotein A1 ratio

APOB TXNL4B LPL

2.23e-03491563EFO_0021897
Diseasefree cholesterol measurement, intermediate density lipoprotein measurement

ABCA1 APOB TXNL4B LPL

2.29e-031041564EFO_0008591, EFO_0008595
Diseasefree cholesterol in LDL measurement

APOB TXNL4B LPL

2.37e-03501563EFO_0022266
Diseasefemoral neck bone geometry

NSD1 FGFR4

2.42e-03141562EFO_0004511
Diseasesitting height ratio

NSD1 MECOM FGFR4

2.51e-03511563EFO_0007118
Diseasefree cholesterol to total lipids in small HDL percentage

ABCA1 APOB MADD

2.51e-03511563EFO_0022285
Diseasephospholipids in medium VLDL measurement

APOB TXNL4B LPL

2.65e-03521563EFO_0022154
Diseasetotal lipids in LDL measurement

ABCA1 APOB TXNL4B

2.65e-03521563EFO_0022308
Diseaselow density lipoprotein triglyceride measurement

APOB LPL

2.79e-03151562EFO_0009946
DiseaseWilliams-Beuren syndrome (implicated_via_orthology)

LIMK2 NOP2

2.79e-03151562DOID:1928 (implicated_via_orthology)
DiseaseReplication Error Phenotype

SETD2 TARBP2

2.79e-03151562C1721098
DiseaseMicrosatellite Instability

SETD2 TARBP2

2.79e-03151562C0920269
Diseasetriacylglycerol 52:3 measurement

APOB LPL

2.79e-03151562EFO_0010415
Diseaseinfant head circumference

ZBTB38 STRBP

2.79e-03151562EFO_0004577
DiseaseHypertriglyceridemia

APOB LPL

2.79e-03151562C0020557

Protein segments in the cluster

PeptideGeneStartEntry
PGGTISSELKHKIKF

TDRD5

291

Q8NAT2
QKTAHPLGVKLVFSK

ZNF385D

311

Q9H6B1
KHLIPAANTGESKVF

YWHAE

106

P62258
NGTNLKKIHVSPDFK

APAF1

1216

O14727
SPFDHKKTVSGFQKL

CDY2A

146

Q9Y6F7
SLKTKAFQAHTPAQK

BAZ2B

1196

Q9UIF8
NLKDKFIKHFTGPVT

ALKAL1

71

Q6UXT8
NIHFRGKTKSFPEEK

GSDMB

221

Q8TAX9
EKKLHAVPAGNTVKF

FGFR4

156

P22455
VSKAKHLQFISGVKP

ABCA1

1681

O95477
TLKQFHIKLKTPGVD

ARFIP1

351

P53367
KKSLSPEQDIKFSGH

ACOT9

156

Q9Y305
KGHNPRSSIAVKLFK

ADRA1B

271

P35368
QKLFTKSHSLEGPSK

DLGAP1

146

O14490
LAFKKIPQKSSHAVC

GKAP1

76

Q5VSY0
KSNVIPIGHVKKGIF

ARMC3

781

Q5W041
KKHKAPAAAVVRAAV

DHX29

6

Q7Z478
ASHASLIPETGKKKV

BMP4

21

P12644
VGKVSVFFRTSPKHK

ATP2C2

641

O75185
KAINALKSFHKPVTS

POLL

281

Q9UGP5
SPKEFVHLAGKSTLK

GMEB2

126

Q9UKD1
PKRTSVKKGHIQFEA

NSD1

506

Q96L73
KKEKHSLAPNVVAFT

RALGPS1

81

Q5JS13
KSIHSFGFPNFVKKI

MMP12

366

P39900
IRKGTKAPQAAGKIH

OLA1

321

Q9NTK5
KAPQAAGKIHTDFEK

OLA1

326

Q9NTK5
VQTLVHLKFPTKVGK

GDF2

376

Q9UK05
TKLTEPRKNHVFGGK

MECOM

786

Q03112
SIEKLPVFNKSAFKH

PDK4

371

Q16654
ATAKFHVTPLFGNVK

FIGNL1

211

Q6PIW4
TTKQHKFEDLTPGKK

PTPRB

1046

P23467
HKAAVSVLKPFSKGA

LRRC37A3

1241

O60309
TIFGKAHSLKPSIKE

MADD

1251

Q8WXG6
PKIKNGKHTFSEVEV

CD46

166

P15529
KKVVTKTFHGTGLVP

nan

216

A8MVJ9
HKAAVSVLKPFSKGA

LRRC37A2

1241

A6NM11
HKAAVSVLKPFSKGT

LRRC37A

1241

A6NMS7
GKPHTEVKINRKTAF

NEIL3

371

Q8TAT5
SKGQQKAHVSFKPTV

ITIH2

241

P19823
PKHVVKGKQVSVALS

NUDCD3

206

Q8IVD9
GVDTKAIKSFPAHLA

RPS6KC1

541

Q96S38
ATVKHAKSPGTKFLL

LIPM

216

Q5VYY2
KSQTKENKVGTSFPH

GPBP1

226

Q86WP2
FFGQAIKVTHKATGK

LIMK2

341

P53671
PQKVVDAARKHGVKL

HAGH

81

Q16775
PKQEEVSFFHGKKTT

KIF18A

46

Q8NI77
KHKKSQKGSAFTFPS

KCNQ3

581

O43525
SHLQKGKAPAVFVKC

LPL

451

P06858
IHSSKPKVKDAVQAV

ODR4

291

Q5SWX8
SHFSLNVKTLKDGKP

PCDHGC5

176

Q9Y5F6
SSQFPKHLIVAIGVK

CWF19L2

681

Q2TBE0
KPTHFTVLTKGAGKA

FLNC

886

Q14315
SVRKSGKHVTNSPFK

FLNC

2016

Q14315
SKFPKKLHTDVVENG

ABCC11

1261

Q96J66
NAKKKEVAGAKPHIT

IMMT

311

Q16891
HKKEKKGAQDPTAFS

KNOP1

151

Q1ED39
IRKVPGNFTFTHKKV

IL10RA

171

Q13651
TGLKFSPHLVNTVFK

MICU3

466

Q86XE3
VQVFASGKPKISAHR

AP5M1

451

Q9H0R1
KRGKFSEFKAHTAPV

POC1B

91

Q8TC44
QFVHEVKKSPFGKDV

DDX11

241

Q96FC9
LAILKDSKGKFHVTP

FOXRED2

286

Q8IWF2
APGFQKKFHEKVIAA

IPO5

431

O00410
IIPKSKESHFVFSKQ

GREB1L

1481

Q9C091
EKHGLEKPISFVKNT

NBAS

1051

A2RRP1
TKHAKVLFRASGGKP

NPHP4

1101

O75161
LNKVLGIKHFDPSKA

HMMR

676

O75330
KSVHTDKPGAKQFFQ

PARP14

741

Q460N5
EAQVRAAPAKKHTGK

FAM9A

61

Q8IZU1
VNKQKLFEKSTGLPH

ITGB3BP

146

Q13352
KTPQHVKITDFGLAK

EGFR

846

P00533
KFSHVEKLGNNPVSK

APOB

1436

P04114
QLVAASKVKANKHSP

HIP1R

916

O75146
NKSVLVPHGSKLKVV

GBE1

131

Q04446
AKKVVKTHEPASFNL

C17orf99

71

Q6UX52
KVKNVHTDGFQKPTH

BCLAF3

591

A2AJT9
KQKVKTIFPHTAGSN

BAIAP2L1

341

Q9UHR4
AGPAKVFVKIKASHA

DACT3

596

Q96B18
HKQKIFLTISFGGIK

DAB1

81

O75553
LLGFHTASGKKVKIA

BRCA2

1521

P51587
ETEKPKLKATGHVFQ

BTAF1

1556

O14981
KSKTSQSHLEFVPKG

GCNT7

241

Q6ZNI0
KPTHFTVNAKAAGKG

FLNA

891

P21333
ETKSARVKGLSFHPK

COPA

6

P53621
IFPKVLGKSQSKHIS

GALNT5

346

Q7Z7M9
IKAFKDKQIHPGFGS

EGR3

231

Q06889
LAQFVHEVKKSPFGK

DDX11L8

241

A8MPP1
KATFGPAIAAVQKFH

DDX11L8

886

A8MPP1
TGNAILGKHVFKSKF

GIMAP8

26

Q8ND71
KVNSQKPGFIKVVRH

GALNT18

211

Q6P9A2
KPGFIKVVRHSKQEG

GALNT18

216

Q6P9A2
DTIPKKVVCHFSGKA

CRIM1

811

Q9NZV1
HILQTLFGKKKSFDP

DIDO1

1316

Q9BTC0
EVKARLQKFIHKPGS

CBL

276

P22681
HSSVQKKAKGPVHIV

EMC1

771

Q8N766
GKLAASVHQATKAKP

DCLRE1A

416

Q6PJP8
NNASVKVKGPAHKIS

DHRS7C

126

A6NNS2
FKHNPKINTIFISKV

ERCC3

596

P19447
GHRKAVTVVKFNPKI

HIRA

266

P54198
FHAATTAGKLVSLPK

SDS

201

P20132
GTPKHFAEAKEFVKQ

OLAH

161

Q9NV23
PKTSFGIKQEHKVLI

MAP3K19

726

Q56UN5
GFIKPTKQKTDHVAR

ORC3

691

Q9UBD5
LKIPSAAGKHKAFST

OR1L3

226

Q8NH93
VSENPGQIKFHAVKK

FBXL21P

266

Q9UKT6
AFHNFIKVTLTKSPK

MAP4K1

246

Q92918
VAKIQAKIPGAKRHA

RTN1

761

Q16799
IHKAVNLPAKDFSGT

SYT9

241

Q86SS6
ISHVPENTKGAVKKH

TAAR3P

231

Q9P1P4
FQAVLLQPHKKSSTK

ATP6V1C2

361

Q8NEY4
FEGKVNLKKPQHVFS

TRMT11

136

Q7Z4G4
VNTVPLKNKKASSFH

TBC1D22B

46

Q9NU19
FTFAPHKKVLTKNLS

TAGAP

511

Q8N103
KHKTFLPVKGNTEKS

RESF1

1616

Q9HCM1
QIKKSPAVKVTHFKG

LAMA1

2256

P25391
THVKTSNLAAPKSGK

SPATA31A7

766

Q8IWB4
KKFGTINIVHPKLGS

PSAT1

116

Q9Y617
FEKHSKLPAAKGFVA

POLR3A

821

O14802
HFVRSQDKLKTPLGK

RUFY4

86

Q6ZNE9
ASGPSKKTAKLHVAV

STRBP

431

Q96SI9
KPKVVKGRAEAHFSL

MYH3

566

P11055
GPRKKIANFVEHKAA

SEC23IP

691

Q9Y6Y8
HPKKASFQKLNGISK

NOP2

641

P46087
FCKHLGGTQKTAVPK

ACOT4

406

Q8N9L9
ELVVTIPKNSHKKGA

BRD2

186

P25440
TGKFTSQAEKHLPRK

CLSPN

916

Q9HAW4
AVKTHSEVRKKPVFQ

CNOT10

711

Q9H9A5
GKVSPTAKTKSLLHF

COL24A1

11

Q17RW2
KASHFGPFIAKKVIG

TTPAL

196

Q9BTX7
THVKTSNLAAPKSGK

SPATA31A3

766

Q5VYP0
TKATKQAGKARPSAH

TNRC18

2701

O15417
QPVRKVQSATHFKKV

VPS4B

351

O75351
LKKSIDSFGQVSHPK

SPATS2

361

Q86XZ4
KSILGNKKFHTGEIP

ZNF132

276

P52740
KTHSEKFQGVKTPSQ

TPTE

376

P56180
GKAFTFKSQLIVHKG

ZNF268

646

Q14587
GHTAFLVKLRKVKPQ

TRMT61B

461

Q9BVS5
ESGKPGAHVTVKKLF

HNRNPA2B1

101

P22626
AKHQPTAIIAKTFKG

TKT

231

P29401
THVKTSNLAAPKSGK

SPATA31A1

766

Q5TZJ5
THVKTSNLAAPKSGK

SPATA31A5

766

Q5VU36
SLLFVKKKNGLHFPS

THAP9

751

Q9H5L6
KDSIKHLSLQPFQKG

RREB1

431

Q92766
TSSSGALKKQHKKPF

TUBE1

241

Q9UJT0
KVEAFKGKILCQSHP

SPATA31D1

1501

Q6ZQQ2
HINVSPKAVKNTDGK

SCEL

471

O95171
FIKKFLSNKPSALHG

nan

131

Q6ZSR6
KKQAAPHLKAEVGNS

TRPV2

416

Q9Y5S1
RKASQLVGIEKKFHP

UBE2T

181

Q9NPD8
ATSHLPNKGALAKVK

PHF19

16

Q5T6S3
SVKPGAHLTVKKIFV

HNRNPA3

116

P51991
PDKSSGKSHIEKLIF

PLEKHH1

1291

Q9ULM0
KVEIKFQGQHVAKSP

POGLUT2

111

Q6UW63
PQTDKFFLHKGTEKN

SETD2

1126

Q9BYW2
VKFTVHTKSSLPNFK

SNX6

46

Q9UNH7
KSVTQQIHFKKTSGP

ZSCAN22

196

P10073
HSASCQIKVFKPKGA

UBP1

226

Q9NZI7
HSAFQAPAVKKKPTV

TRAM1

326

Q15629
LFQKPFSSGKTITKH

SLC30A5

76

Q8TAD4
FKSPKLAKHAAVFSG

ZNF165

326

P49910
IDQAQKHSKKAGTPA

TNNT3

246

P45378
SGKIFKAHKNILVAG

ZBTB10

371

Q96DT7
QGPSKKAAKHKAAEV

TARBP2

76

Q15633
SPDHTKFVGSFKTKQ

TXNL4B

96

Q9NX01
VPIFKQFHKNIIGKG

HDLBP

586

Q00341
KHLFKSPSQQEKIGD

ZBTB38

1146

Q8NAP3
KKKISHIAEQSPSAG

TOGARAM1

1066

Q9Y4F4
FTGDTLKPKHQQKSS

SETBP1

201

Q9Y6X0
LPVVSSVVKVKKFNH

ZC3H14

296

Q6PJT7
GKAFPRSSALKQHKK

ZNF485

416

Q8NCK3
QASQVKHKPTAVVAK

TKTL1

201

P51854
KHKPTAVVAKTFKGR

TKTL1

206

P51854
GKLPVGKHNFSKIIS

ZBTB40

81

Q9NUA8
KIHILPTNAKVGSKF

nan

116

Q9UFV3